Skip to main content

Notice of Intent to Revise: Bupropion Hydrochloride

Type of Posting: Notice of Intent to Revise
Posting Date: 19-Feb-2021
Targeted Official Date: 01-August-2021; Revision Bulletin
Expert Committee: Small Molecules 4

In accordance with the Rules and Procedures of the Council of Experts, this is to provide notice that the Small Molecules 4 Expert Committee intends to revise the Bupropion Hydrochloride monograph.

The Expert Committee proposes to revise the Bupropion Hydrochloride monograph to replace the incorrect reference to USP Bupropion Hydrobromide RS with a correct reference to USP Bupropion Hydrochloride RS in the System suitability solution description within the Assay.  

It is anticipated that the proposed revision will be published as Revision Bulletin on April 30, 2021 pursuant to the Rules and Procedures. 

Should you have any questions, please contact Heather Joyce, Senior Scientific Liaison – Team Lead (